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to 1 for a = 0.1, 0.2, · · · , 1.9 and π = 0.1, 0.2, · · · , 1.
The simulation is conducted as follows. For each triplet (a, π, tp), 5000 indepen-
dent samples are simulated from model
Xp
△




where random variables Tp, ε and η are independent; Tp has a distribution such that
P (Tp = tp) = π and P (Tp = 2) = 1−π; ε and η have uniform distribution U(−a, a),
a = 0.1, 0.2, 0.3, · · · , 1.9 and π = 0.1, · · · , 1 with increments of 0.1 respectively;
tp = 1, 2, · · · , 9 with increments of 1. The mean and median of Xp(a, π) are estimated














, a = 0.1, 0.2, · · · , 1.9,
















and reported in Tables 1 and 2, which follow, where s2(π) is given within the paren-
theses.
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Table 1: The values of m(π, tp) and s
2(π, tp) (Part A)
π = 1
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9988320 0.9999922 1.0006107 0.9996400 1.0010851
(1.204417e-05) (6.722244e-06) (5.334313e-06) (1.261637e-05) (1.167334e-05)
tp = 6 tp = 7 tp = 8 tp = 9
0.9996429 1.0007002 0.9996422 0.9995458
(1.231912e-06) (5.472384e-06) (5.472957e-06) (4.414939e-06)
π = 0.9
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0234726 0.9999251 0.9945141 0.9874093 0.9815765
(7.944477e-04) (3.122031e-06) (7.239544e-05) (2.153089e-04) (3.306295e-04)
tp = 6 tp = 7 tp = 8 tp = 9
0.9784618 0.9754699 0.9728850 0.9690245
(4.723169e-04) (5.685863e-04) (5.824456e-04) (5.801032e-04)
π = 0.8
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0387630 0.9996188 0.9892445 0.9765723 0.9673282
(2.886933e-03) (9.836780e-06) (2.590746e-04) (8.382101e-04) (1.415877e-03)
tp = 6 tp = 7 tp = 8 tp = 9
0.9586696 0.9522338 0.9460126 0.9428445
(1.799211e-03) (2.116493e-03) (2.245196e-03) (2.510819e-03)
π = 0.7
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0490667 1.0001018 0.9855943 0.9663545 0.9524253 2
(5.548408e-03) (1.432224e-05) (5.197429e-04) (1.709809e-03) (2.958586e-03)
tp = 6 tp = 7 tp = 8 tp = 9
0.9407424 0.930110 0.9227174 0.9165458
(3.912353e-03) (4.538055e-03) (5.050342e-03) (5.479345e-03)
π = 0.6
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0488169 1.0010726 0.9854699 0.9623178 0.9414670
(7.753325e-03) (6.911221e-06) (7.413494e-04) (2.893487e-03) (4.946303e-03)
tp = 6 tp = 7 tp = 8 tp = 9
0.9257995 0.9128190 0.9026656 0.8949812
(6.682264e-03) (8.140030e-03) (9.115055e-03) (1.010583e-02)
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Table 2: The values of m(π, tp) and s
2(π, tp) (Part B)
π = 0.5
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9976367 1.0008558 1.0051801 1.0075940 1.0563732
(3.009497e-03) (3.751868e-06) (1.132037e-03) (8.828197e-03) (3.143084e-02)
tp = 6 tp = 7 tp = 8 tp = 9
1.0996647 0.9949510 1.0348440 1.2778189
(5.681301e-02) (3.069008e-02) (5.681301e-02) (3.069008e-02)
π = 0.4
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9689243 1.0004657 1.0224327 1.0774329 1.1533009
(2.197164e-03) (8.269312e-06) (1.544194e-03) (1.112485e-02) (3.060863e-02)
tp = 6 tp = 7 tp = 8 tp = 9
1.2460811 1.3484609 1.4610660 1.5757287
(5.815739e-02) (9.379170e-02) (1.286891e-01) (1.732840e-01)
π = 0.3
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9690245 1.0008585 1.0242324 1.0860159 1.1647982
(1.446965e-03) (3.876559e-06) (1.226318e-03) (6.909656e-03) (1.727091e-02)
tp = 6 tp = 7 tp = 8 tp = 9
1.2629289 1.3679820 1.4846238 1.5987995
(2.912726e-02) (4.057614e-02) (5.020234e-02) (5.951541e-02)
π = 0.2
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9737273 1.0001785 1.0231539 1.0743057 1.1446959
(6.463392e-04) (3.456922e-06) (5.653691e-04) (3.026114e-03) (6.303903e-03)
tp = 6 tp = 7 tp = 8 tp = 9
1.2239605 1.3104238 1.3991247 1.4862704
(9.262918e-03) (1.097795e-02) (1.232603e-02) (1.325612e-02)
π = 0.1
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9836251 0.9996371 1.0143460 1.0458579 1.0869769
(1.448035e-04) (1.181245e-05) (1.537200e-04) (6.429722e-04) (1.166530e-03)
tp = 6 tp = 7 tp = 8 tp = 9
1.1335024 1.1808455 1.2294815 1.2743215
(1.374409e-03) (1.518496e-03) (1.587512e-03) (1.669519e-03)
3
The Monte Carlo simulation results clearly show that all the sample means
m(π, tp) are close to 1 and the sample variance s
2(π, tp) are close to 0. There-




≈ 1, for any a ∈ (0, 2), π ∈ (0, 1)
and tp ∈ {1, · · · , 9}.
Figure 1: The plot of the mean of gains/losses obtained at each probe position using
the cghMCR method.
Appendix B
The locations of the genes of NR/U, CR and LCR in non-small cell adenocarci-
noma (NA) and related references.
• Probe positions from 1 to 295: A total of 200 genes are found in this region,
28 of them (14%) are genes related to cancer phenotype while 3 (1.5%) are
related to lung cancer phenotype. All LCR genes are located in chromosomal
regions identified as losses by both methods (LM and cghMCR). The LCR
genes located at this region are PSIP1, CDKN2A, and TUSC1. PSIP1 and
CDKN2A, a well-known lung cancer suppressor1 are both located in a region
frequently found deleted in lung cancer patients2. In addition, TUSC1 is found
mutated and silent in nonsmall cell lung carcinoma cell lines3.
• Probe positions from 296 to 331: A total of 12 NR/U genes are found in this
region.
• Probe positions from 332 to 341: Only 3 genes are located in this region with
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Figure 2: The plot of the mean of copy numbers obtained at each probe position
using the linear-median method.
one of them being classified as CR (ACO1). Both methods identify the region
where this gene is located as loss.
• Probe positions from 342 to 375: A total of 113 genes are located in this
regions with 14 of them being classified as CR.
• Probe positions from 376 to 500: A total of 171 genes are located in this
region. Four of them are CR and only one (IGFBPL1, classified as loss by
both methods) is classified as LCR. IGFBPL1 has already been shown to be
downregulated in lung tumor samples4.
• Probe positions from 501 to 1234: A total of 744 genes are located in this re-
gion, 90 of them being classified as CR, and 9 as LCR. The cghMCR method
does not identify any region containing LCR as altered. On the other hand,
the LM method identifies five of the LCR genes in chromosomal regions of
loss (TLE1, FRMD3, DAPK1, MIRLET7A1, PTPN3) and, consequently, are
expected to have lower expression in lung tumor samples. In fact, TLE1 is
frequently found altered in squamous cell carcinomas and adenocarcinomas5
while FRMD3 expression is usually silenced in primary nonsmall cell lung
carcinomas6. Likewise, mouse lung carcinoma clones characterized by highly
aggressive metastatic behavior did not express Dapk17. Also, MIRLET7A1
5
Figure 3: The plot of the median of copy numbers obtained at each probe position
using the linear-median method.
and PTPN3 expressions are downregulated in lung cancer8,9. The LM indeti-
fies one gene located in a gain region (GAS1), and therefore, it is expected to be
overexpressed in lung cancer samples. Surprisingly, Gas1 expression is known
by its capacity of suppressing metastasis in lung10, therefore, we hypothesize
that the this gene might be regulated epigenetically or it is a false positive
identified by the LM method. Again, the cghMCR method does identifies this
region as neutral. In addition, 3 genes are found by both methods in neutral
regions (PHF19, DAB2IP, RPL12) and, therefore, we believe that their regula-
tion is being performed by epigenetic factors. In fact, PHF19 mRNA is known
to be overexpressed in lung cancers9 as well as methylation of the promoter
of DAB2IP is associated with the lung cancer phenotype11. Likewise, RPL12
splice variant are frequently found in human lung carcinoma cell12.
• Probe positions from 1235 to 1249: A total of 17 genes are located in this
regions with only one of them (ABL1) being classified as CR and identified as
a gain by both methods.
Appendix C
R code for the linear-median function
♯ x is an n×T matrix, the elements of y are aCGH observations in linear format
6
♯ n denotes the number of independent samples
♯ T denotes the size of each individual sample
♯ At any probe position p, if the true shared copy number is not 2, the probability
of having copy number changed is “prob”.
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Table 3: The true positive (TP) rates and false positive (FP) rates for the linear-
median method and the cghMCR method where n = 20.
n = L-M cgh L-M cgh L-M cgh
20 MCR MCR MCR
π a = 0.5 a = 1 a = 1.5
0.2
TP 0.6382 0.0714 0.7568 0.0024 0.8096 0
(0.0496) (0.1101) (0.0406) (0.0188) (0.0414) (0)
FP 0.3785 0.0040 0.6549 2.83e-04 0.7657 0
(0.0384) (0.0154) (0.0384) (0.0041) (0.0357) ( 0)
0.4
TP 0.7849 0.6760 0.7696 0.0308 0.7616 0
(0.0429) (0.1830) (0.0413) (0.0779) (0.0453) (0)
FP 0.0861 0.0415 0.3827 0.0011 0.5611 0
(0.0248) (0.0302) (0.0402) (0.0081) (0.0408) (0)
0.6
TP 0.9503 0.9075 0.8708 0.2759 0.8013 0
(0.0227) (0.0224) (0.0359) (0.1129) (0.0410) (0)
FP 0.0122 2.58e-05 0.2000 0.0023 0.3905 0
(0.0090) (0.0004) (0.0310) (0.0114) (0.0419) (0)
0.8
TP 0.9966 0.9030 0.9451 0.3877 0.8677 0
(0.0060) (0.0206) (0.0204) (0.1308) (0.0331) (0)
FP 0.0013 0 0.0238 0 0.2617 0
(0.0028) (0) (0.0917) (0) (0.0358) (0)
1
TP 1 0.9490 0.9817 0.6542 0.9237 0
(0) (0.0147) (0.0147) (0.1561) (0.0287) (0)
FP 7.74e-05 0 0.04026 0 0.1667 0
(0.0007) (0) (0.0154) (0) (0.0314) (0)
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Table 4: The true positive (TP) rates and false positive (FP) rates for the linear-
median method and the cghMCR method, where n = 50.
n = L-M cgh L-M cgh L-M cgh
50 MCR MCR MCR
π a = 0.5 a = 1 a = 1.5
0.2
TP 0.6309 0.02442 0.7147 0 0.7521 0
(0.0547) (0.0626) (0.0499) (0) (0.0455) (0)
FP 0.1712 6.45e-04 0.4866 0 0.6425 0
(0.0346) (0.0065) (0.0488) (0) (0.0437) (0)
0.4
TP 0.8895 0.6643 0.8574 0.0019 0.7975 0
(0.0347) (0.1542) (0.0357) (0.0109) (0.0420) (0)
FP 0.0089 0.0439 0.1737 0 0.3603 0
(0.0070) (0.0297) (0.0365) (0) (0.0416) (0)
0.6
TP 0.9949 0.9046 0.9581 0.2762 0.8926 0
(0.0072) (0.0149) (0.0212) (0.0842) (0.0358) (0)
FP 6.45e-05 0 0.0482 0 0.1814 0
(0.0006) (0) (0.0189) (0) (0.0364) (0)
0.8
TP 1 0.8962 0.9912 0.3384 0.9545 0
(0) (0.0118) (0.0100) (0.0416) (0.0209) (0)
FP 0 0 0.0100 0 0.0826 0
(0) (0) (0.0082) (0) (0.0238) (0)
1
TP 1 0.9207 0.9992 0.4155 0.9848 0
(0) (0.0154) (0.0029) (0.1679) (0.0107) (0)
FP 0 0 0.0023 0 0.0348 0
(0) (0) (0.0038) (0) (0.0153) (0)
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Table 5: The true positive (TP) rates and false positive (FP) rates for the linear-
median method and the cghMCR method, where n = 100.
n = L-M cgh L-M cgh L-M cgh
100 MCR MCR MCR
π a = 0.5 a = 1 a = 1.5
0.2
TP 0.6771 0.0048 0.7438 0 0.7335 0
(0.0539) (0.0203) (0.0505) (0) (0.0461) (0)
FP 0.0561 0 0.3266 0 0.5146 0
(0.0187) (0) (0.0412) (0) (0.0381) (0)
0.4
TP 0.9566 0.6650 0.9299 0.0004 0.8718 0
(0.0233) (0.1317) (0.02653) (0.0030) (0.0341) (0)
FP 0.0003 0.0455 0.0578 0 0.2012 0
(0.0013) (0.0270) (0.0196) (0) (0.0340) (0)
0.6
TP 0.9998 0.9033 0.9920 02804 0.9556 0
(0.0015) (0.0108) (0.01010) (0.0706) (0.0239) (0)
FP 0 0 0.0065 0 0.0621 0
(0) (0) (0.0075) (0) (0.0224) (0)
0.8
TP 1 0.8956 0.9998 0.3345 0.9922 0
(0) (0.0087) (0.0015) (0.0193) (0.0099) (0)
FP 0 0 0.0003 0 0.0167 0
(0) (0) (0.0013) (0) (0.0125) (0)
1
TP 1 0.8971 0.9998 0.2263 0.9983 0
(0) (0.0177) (0.0015) (0.1156) (0.0044) (0)
FP 0 0 0.0003 0 0.0043 0
(0) (0) (0.0013) (0) (0.0056) (0)
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